Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 2 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Unknown 2Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Neuroblastoma 1Lung Neoplasms 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Population Groups × Clear all
NCT00072358 2022-05-16

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
291 enrolled 7 charts
CNS

Neuroblastoma

NCT01048762 2015-10-22

Multidisciplinary Rehabilitation After Cancer Pulmonis Operation

Aalborg University Hospital

Phase 2 Completed
78 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡